The White House is reportedly preparing a major public health announcement regarding a potential connection between Tylenol (paracetamol) use during early pregnancy and an increased risk of autism in children, according to The Washington Post.
The alert is based on research conducted by Harvard University and Mount Sinai Hospital, which suggests that prenatal exposure to the common painkiller may be linked to a higher likelihood of autism spectrum disorder (ASD). U.S. health authorities are expected to advise women to avoid taking Tylenol during the early stages of pregnancy.
In a related development, officials are also highlighting Leucovorin (calcium folinate) as a potential treatment option for children with autism. Typically prescribed to mitigate side effects of certain medications and to treat vitamin B9 deficiency, early studies indicate that Leucovorin may improve speech and comprehension in children with ASD. However, the broader scientific community remains divided over the drug’s effectiveness.
The upcoming announcement could have significant implications for prenatal care guidance and autism research in the United States.
Stay updated with the latest news from Greece and around the world on greekcitytimes.com.
Contact our newsroom to share your updates, stories, photos, or videos. Follow GCT on Google News and Apple News.
